Please join us for an Open Scientific Discussion (OSD) hosted by the AAPS Therapeutic Product Immunogenicity (TPI) and Biomarkers and Precision Medicine (BPM) Communities on February 21st, 12 - 1 pm ET on the following topic:
Characterizing CD4 T Cell Immune Responses (Part 2)
· What are the complementary assays to a CD4 T cell assay for integrated immunogenicity risk assessment?
· What are the key parameters and considerations for preclinical immunogenicity assays?
· How to qualify a CD4 T cell assay?
Discussion Leaders:
Sophie Tourdot (Pfizer), Sofie Denies (ImmunXperts), Chloe Ackaert (ImmunXperts), and Sofie Pattyn (ImmunXperts)
Organized by: Yi Wen (Lilly), Vibha Jawa (BMS), Carmen Fernández-Metzler (PharmaCadence) and Karen Quadrini (Prothena Biosciences)
We start at 12:00 ET sharp. To avoid interruptions, please dial in before noon and mute yourself until Q&A starts.
(Please remain on mute unless asking questions)
When: Wed, Feb 21, 2024, 12 pm – 1 pm ET
Where: Please join from your computer, tablet or smartphone.
https://global.gotomeeting.com/join/305789893
You can also dial in using your phone.
United States: +1 (872) 240-3412
Access Code: 305-789-893
Join from a video-conferencing room or system.
Dial in or type: 67.217.95.2 or inroomlink.goto.com
Meeting ID: 305 789 893
Or dial directly: [email protected] or 67.217.95.2##305789893
New to GoToMeeting? Get the app now and be ready when your first meeting starts:
https://global.gotomeeting.com/install/305789893
Please feel free to share with colleagues who may be interested in this topic.
Thank you,
The Leadership Teams of the AAPS TPI and BPM Communities
------------------------------
Yi Wen Ph.D.
Sr. Director
Eli Lilly and Company
Indianapolis IN
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------